LigaChem Biosciences

141080.KQ

83.15 USD

0.55

+0.67%

Overview

Last close

83.15 usd

Market cap

3.02B usd

52 week high

99.94 usd

52 week low

24.64 usd

Target price

108 usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

56.3636

Price/Book Value

6.7405

Enterprise Value

2.63B usd

EV/Revenue

37.2576

EV/EBITDA

3297.9143

Key financials

Revenue TTM

52.99M usd

Gross Profit TTM

41.85M usd

EBITDA TTM

-33.73M usd

Earnings per Share

N/A usd

Dividend

N/A usd

Total assets

535.25M usd

Net debt

N/A usd

About

LigaChem Biosciences Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs. The company researches and develops products for various therapeutic areas, including antibiotics, anti-fibrotics, immuno-oncology, oncology; and antibody-drug conjugate (ADC) platform technology and small molecule drugs. It also sells medical device and supplies. It has a research collaboration and license agreement with AMGEN for the development and commercialization of ADCs. The company was formerly known as LegoChem Biosciences, Inc. and changed its name to LigaChem Biosciences Inc. in April 2024. LigaChem Biosciences Inc. was founded in 2006 and is headquartered in Daejeon, South Korea.